Predicting Liver Injury from Immunotherapy in Liver Cancer
In a groundbreaking study published in BMC Cancer, researchers have made strides in understanding and predicting liver injury induced by immune checkpoint inhibitors (ICIs) in patients suffering from hepatocellular carcinoma (HCC). As ICIs revolutionize systemic cancer therapies, their unintended hepatic side-effects emerge as significant clinical challenges. This retrospective analysis offers new insights into the risk […]
In a groundbreaking study published in BMC Cancer, researchers have made strides in understanding and predicting liver injury induced by immune checkpoint inhibitors (ICIs) in patients suffering from hepatocellular carcinoma (HCC). As ICIs revolutionize systemic cancer therapies, their unintended hepatic side-effects emerge as significant clinical challenges. This retrospective analysis offers new insights into the risk […]
What's Your Reaction?
